Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mite-E-Wak
- Development stage
- Unknown
- Lead developer
- Chumakov Federal Scientific Center
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
Mite-E-Wak (also known as Tick-E-Vac or Kleshch-E-Vac) is an inactivated whole-virion vaccine developed and manufactured by the Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of the Russian Academy of Sciences (Chumakov FSC R&D IBP RAS). The vaccine is produced by cultivating the tick-borne encephalitis (TBE) virus in primary chicken embryo fibroblast cells, followed by inactivation and purification. It is designed to stimulate the production of neutralizing antibodies against the TBE virus, providing active immunity against the disease. The vaccine is approved in Russia for use in children from 1 year of age and adults, typically administered via a primary two-dose intramuscular schedule followed by periodic boosters.
- Brand names
- Mite-E-WakTick-E-VacKleshch-E-Vac
- Other names
- Tick-borne encephalitis vaccine culture purified concentrated inactivated
Beyond the preview
Go deeper on Mite-E-Wak.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mite-E-Wak.